Dissemin is shutting down on January 1st, 2025

Published in

Endocrine Abstracts

DOI: 10.1530/endoabs.38.ja4

Wiley, Clinical Endocrinology, 1(82), p. 136-141, 2014

DOI: 10.1111/cen.12559

Links

Tools

Export citation

Search in Google Scholar

Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS)

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Objective The aim of this study was to determine the extent of drug interactions affecting levothyroxine, using study drugs often co-administered to patients on long-term levothyroxine therapy. Design A retrospective population analysis linking biochemistry and prescription data between 1 January 1993 and 31 December 2012 was used. Patients The study population was Tayside residents prescribed levothyroxine on at least three occasions, within a six month period, prior to the start of a study drug. Individuals acted as their own controls pre- and post-initiation of study drug. Overall 10,999 patients (mean age 58 years, 82% female) being treated with thyroxine were included in the study. Measurements Changes in TSH following initiation of study drug. Results Iron, calcium, proton pump inhibitors, and oestrogen all increased serum TSH concentration: an increase of 0.22 mU/L (p